Year: 2017

These Analysts Insist Wirecard AG (FRA:WDI) Remains Considerably Undervalued

Wirecard AG (FRA:WDI) (OTCMKTS:WRCDF) (OTCMKTS:WCAGY) took a real hit last year when the company found itself on the wrong end of an unwarranted short attack. Despite being one of the biggest payments processors in the world, large portions of the market chose to take the word of an unknown research organization as more reliable than that of the analysts following the stock and wiped off more than 30% of Wirecard’s market capitalization between January 2016 and March the same year.

As is to be expected, with the accusations proving baseless, Wirecard has appreciated considerably across the 12 months subsequent to its March 2016 lows. Despite this appreciation, however, analysts still expect Wirecard’s share price to rise throughout the second quarter of 2017 and beyond.

Here is a look at where these analysts think this growth is coming from and what price target each has on the company right now.

Before we get started on the price targets, and for those not yet familiar with Wirecard, we’ll kick things off with a quick introduction to the company.

It is a German-based entity that – at last count – served more than 170,000 clients across the globe. These range from small individual retailers doing business online to large multinational corporations using Wirecard’s services as a full suite payment processing framework for their various operational activities.  Outside of its technology offerings, Wirecard Provides consultation type services, with things like relationship management, risk control and expansion strategy guidance all underlying the existing relationships it shares with the clients on its books.

Just recently, and on the back of the company’s acquisition of the prepayment card operations of US banking giant Citigroup Inc (NYSE:C), Wirecard expanded into the US. In doing so, the company has taken a considerable step towards overtaking its primary competitor, and the leader in the space from a client count perspective, Worldpay Group PLC (LON:WPG). The move marks the company’s first foray into the North American market and sets the stage for industry leadership in the fast-growing payments processing sector.

Now let’s look at the expectations of various analysts.

For the purposes of this discussion, we’re going to focus on five institutional analyses. These are those of Hauck & Aufhäuser, Baader, Commerzbank, Berenberg and Godman Sachs.

First then, Hauck & Aufhäuser.

This firm put out its latest Wirecard report on April 10, 2017, subsequent to the company’s conference call. Based on the call in question, H&A kicked off the report with a reaffirmation of its opinion that Wirecard holds a leading market position for payment service and risk management solutions for merchants globally and followed up with the opinion that the growth potential for the company is not fully reflected in the then-current share price of €53.

The growth potential, according to H&A, is rooted primarily in the global shift towards more efficient payments processing. The firm highlighted the fact that currently only 6-7% of transactions are processed efficiently. Accordingly, Wirecard is positioned to take advantage of the inevitable push to increase this percentage figure. Wirecard put out guidance last month for 2017 revenues of between €382-400 million and H&A, in its report, reinforced the company’s ability to meet the high end of this guidance, if not outpace it altogether.

The price target the firm placed on Wirecard at the time of its report was €65. At the time of writing (this report) the company trades for €58, suggesting a 12% premium.

Next, Baader.

Baader’s latest report came on April 18, 2017. Most notably, as part of this report, Baader suggested that the company’s guidance for 2017 understated the company’s potential. A number of inputs fed into this suggestion, primarily that Wirecard’s 2016 financials showed no signs that organic EBITDA growth should slow in 2017 (organic EBITDA growth was 26% in 2015 and 27% in 2016; guidance for 2017 at mid-point: +24%) and that M&A costs should decrease during 2017, as compared to 2016.

Baader made a point of noting that the above-mentioned acquisition of the Citi operations was included in these estimates. Based on these assumptions, Baader estimates an outperformance on Wirecard’s 2017 guidance, suggesting EBITDA could reach €408 million (€8 million above the higher threshold of the €400 million guidance given by the company last month).

Based on its analysis, Baader has a €70 price target on Wirecard – a 20% gain on the company’s current price.

Moving on, Commerzbank.

The Commerzbank report highlights the fact that Wirecard remains one of its top secular growth plays. The research report pointed to a slight acceleration of organic revenue growth during the first quarter of the year contributing to as underpinning revenue of €276m. The company’s preliminary estimates for this number actually came out as €274 million, representing a circa 31% increase on the €210 million reported during the same period in 2016.

Just as with the other analysts covering this stock, Commerzbank pointed to industry expansion in the payments processing space (and the drive for efficiency therein) as fundamental to Wirecard’s growth potential going forward. This was a common thread throughout the majority of the company’s analyst coverage.

Looking at a price target, Commerzbank has Wirebank at €65. The company was trading for €53 at the time of the target’s placement, implying a 22% performance to its then-price and a 12% premium to current pricing.

Next, Berenberg.

This is one of the more conservative reports on our list, yet it still presents a significant upside potential to the company’s current share price. Berenberg highlights the Citi acquisition as being key to Wirecard’s growth potential, with this suggestion primarily rooted in its impact on shareholder opinion. Specifically, Berenberg notes that the acquisition has proven to investors that Wirecard’s relationship with the US authorities is not as poor as some believed and that this paves the way for further expansion in North America going forward. It goes without saying that North America is a key market in the electronic payments space and, as such, any indication that Wirecard is overcoming hurdles to expansion within this market is almost certain to support and strengthen bullish sentiment.

We noted that Berenberg has a conservative opinion when compared to some of the above reports, but this conservatism refers to its price target only. Berenberg believes that Wirecard can outperform on its guidance of €400 million for 2017, with €404 million listed as a most likely scenario and €421 million as blue-sky.

Finally, Goldman Sachs.

Goldman Sachs is one of the only reports on this list to highlight the potential for growth in Asia (on the back of a spate of recent acquisitions in the region) as fundamental to its forward thesis on the stock.

Further, Goldman notes that Wirecard should benefit from an increase in the scale of its operations over time, stating that this will lead to a proportional increase in the company’s transaction volume per merchant.

Looking at the firm’s price target, Goldman falls in line with both Commerzbank and H&A in its placing of a twelve-month target of €65 on Wirecard. That’s a 23% premium to Wirecard’s price at the time of Goldman’s report publication, and as noted above, represents a 12% premium to the company’s current price.

 

read more

WSTRF Shareholder Update News

TORONTO and NUCLA, Colo., Aug. 21, 2017 (GLOBE NEWSWIRE) — Western Uranium Corporation (CSE:WUC) (OTCQX:WSTRF) (“Western” or the “Company”) is pleased to provide an update to shareholders and the market.

WSTRF Western is investigating re-starting its vanadium-rich mines as the result of the higher vanadium price, currently $9.50 per pound. The 2017 forecast global production of vanadium is about 80,000 tonnes compared to the forecast consumption of 88,000 tonnes, implying a supply deficit of approximately 8,000 tonnes in the global vanadium market. As vanadium inventories have been depleted, global steel mills are competing against the growing vanadium redox battery (VRB) industry for consistent vanadium supplies. The VRB market could represent another 7,000 to 30,000 tonnes of vanadium demand per annum over the next ten years.

WSTRF stock news

The reason for the decrease in supply and increase in price of vanadium is the Chinese government forcing some factories and iron ore mines to curtail operations to reduce air pollution. Vanadium is a unique commodity market, as China is both the largest producer and consumer of vanadium. China accounts for about 45% of the world’s vanadium production while Russia and South Africa account for approximately another 30% of global vanadium production.

WSTRF has begun discussions on the economics of building a vanadium and ferro-vanadium processing plant. Ferro-vanadium is a higher value product than vanadium pentoxide, enhancing margins for the Company and shareholders.

Finally, discussions have begun with potential vanadium offtake partners both domestically and internationally.

The aforementioned discussions are early stage and the Company will update the market when further news can be released.

Further, WSTRF Western also announces it has received a bonus payment of $120,000 from signing an oil and gas lease on one of its properties in a hydrocarbon rich region. If oil and/or gas is found, the Company will receive a significant royalty percentage which will be reinvested in the Company’s core vanadium and uranium mining operations. The oil and gas leasing agreement allows the Company to retain full property rights to vanadium, uranium, and other mineral resources.

These strategic positioning decisions are being evaluated relative to cash flow generation potential.  Western is seeking to capitalize on the vanadium and royalty opportunities to generate meaningful cash flow by optimizing and advancing the asset package, in spite of the current low uranium price environment.  These actions would have the added benefit of advancing uranium operations in preparation for when the cycle turns and the market recognizes the imminent global uranium supply deficit.

About Western Uranium Corporation
Western Uranium Corporation is a Colorado based uranium and vanadium conventional mining company focused on low cost near-term production of uranium and vanadium in the western United States and development and application of ablation mining technology.

for more info click link : 

 

Click For Disclaimer

read more

KAYS Marijuana Company Kaya Holdings (OTCMKTS:KAYS) Announces Property Purchase Agreement

(OTCMKTS:KAYS) Marijuana Company Kaya Holdings 10-Q Details Increase in Institutional Financing Agreement to $6.3M, Targets Property Purchase for Cannabis Production Facility

Aug 22, 2017
OTC Disclosure & News Service

FORT LAUDERDALE, Fla., Aug. 22, 2017 (GLOBE NEWSWIRE) — Kaya Holdings, Inc. (OTCQB:KAYS), filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 yesterday afternoon. This confirmed KAYS’ continued growth and detailed an agreement for an increase in funding with the Cayman Venture Capital Fund. This will be used for KAY’s purchase of property to build a Cannabis Production Facility in central Oregon.

Full news Release


“KAYS is pleased to confirm the filing of our 10Q for the period ending June 30, 2017. We are very excited by the growth components that we have developed over the quarter. As we look forward to completing a targeted property purchase, on which we plan to relocate our grow and establish a state-of-the-art medical and recreational cannabis manufacturing facility,” stated Kaya Holdings CEO Craig Frank. “Additionally, we secured additional financing to support the launch of Kaya Shack™ delivery services.”

KAYS

“Difficulty in transitioning our Portland store from an OHA to an OLCC license resulted in a decline in sales for Q2, year over year, of approximately $50,000. However our cash and other assets have increased by nearly $1mm for the same period. As of June our monthly numbers are on pace to exceed last year’s average monthly revenues by 20%, on an annualized basis. We now have 3 OLCC Licensed Kaya Shack™ marijuana retail outlets, with the 4th location expected to open in Q-3”, continued Frank. “With our growth plan in place, including introducing home delivery service and relocating and expanding our grow and production facility, the Company is taking steps to broaden its market and increase revenues, while lowering costs through more in-house production.”

The Company expects to release full details of the property purchase within the next 2 weeks.

About Kaya Holdings, Inc. (OTCMKTS:KAYS)

Kaya Holdings, Inc. (OTCQB:KAYS) owns and operates Kaya Shack™ legal marijuana dispensaries in Oregon as well as grow and manufacturing operations, which produce, distribute and/or sell premium legal cannabis products under the Company’s own brands, including flower, concentrates, and cannabis-infused baked goods and candies. KAYS is the first publicly-traded U.S. company to own and operate legal marijuana dispensaries and a vertically integrated legal cannabis grow and manufacturing operation.

Important Disclosure

KAYS is planning execution of its stated business objectives in accordance with current understanding of State and Local Laws and Federal Enforcement Policies and Priorities as it relates to Marijuana (as outlined in the Justice Department’s Cole Memo dated August 29, 2013). Also a plan to proceed cautiously with respect to legal and compliance issues. Potential investors and shareholders are cautioned that the Company will obtain advice of counsel prior to actualizing any portion of its business plan. This (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS, Federal, State or Local legal action or changes in Federal Government Policy and/or State and Local Laws may adversely affect business operations and shareholder value.

Forward-Looking Statements

This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe,” “estimate,” “project,” “expect” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of KAYS’ current and future products and services in the marketplace.

For more information please review our periodic and current filings available at www.sec.gov, call 561-210-5784 or visit www.kayaholdings.com or sign up to receive updates.

Disclaimer 

read more

FCBK Receives Business Enterprise Award

CERRITOS, Calif.–(BUSINESS WIRE)–First Choice Bank (OTCQX: FCBK) (the “Bank”) is honored to be recognized once again for the Community Development Financial Institution (CDFI) Fund’s Business Enterprise Award. The Bank has been a recipient every year since 2011.

Editors Comment : FCBK current ppc is $23.50, with very low daily volume. Don’t expect to see much change over the near future.

The Bank is pleased that its commitment and dedication to financing and supporting community activities, especially for low and moderate income communities, is recognized by the US Treasury Department’s CDFI. The CDFI’s 2016 grant award recognizes and rewards the Bank’s continuing efforts to increase its lending and service activities within the economically distressed communities that the Bank serves.

First Choice Bank is a community focused financial institution serving diverse consumers and commercial clients, as a CDFI bank. Peter Hui, the Bank’s Chairman, said, “We are very proud of all of our efforts to make our community prosper. It is gratifying to receive this award as recognition of that commitment.”

FCBK

ABOUT FIRST CHOICE BANK

First Choice Bank, headquartered in Cerritos, California, is a community focused financial institution, serving diverse consumers and commercial clients and specializing in loans to small businesses, Private Banking clients, Commercial and Industrial (C&I) loans, and commercial real estate loans with a niche in providing finance for the hospitality industry. The Bank is a Preferred Small Business Administration (SBA) Lender. Founded in 2005, First Choice Bank has quickly become a leading provider of financial services that enable our customers to grow, maintain strength, and reach unprecedented levels of success. We strive to surpass our clients’ expectations through our efficiency and professionalism and are committed to being “First in Speed, Service, and Solutions.” First Choice Bank stock is traded on the Over the Counter (OTCQX); our Ticker Symbol is FCBK.

The Bank’s web site is www.FirstChoiceBankCA.com.

 

Click For Disclaimer

read more

WSTRF Shareholder Update News

TORONTO and NUCLA, Colo., Aug. 21, 2017 (GLOBE NEWSWIRE) — Western Uranium Corporation (CSE:WUC) (OTCQX:WSTRF) (“Western” or the “Company”) is pleased to provide an update to shareholders and the market.

WSTRF Western is investigating re-starting its vanadium-rich mines as the result of the higher vanadium price, currently $9.50 per pound. The 2017 forecast global production of vanadium is about 80,000 tonnes compared to the forecast consumption of 88,000 tonnes, implying a supply deficit of approximately 8,000 tonnes in the global vanadium market. As vanadium inventories have been depleted, global steel mills are competing against the growing vanadium redox battery (VRB) industry for consistent vanadium supplies. The VRB market could represent another 7,000 to 30,000 tonnes of vanadium demand per annum over the next ten years.

WSTRF stock news

The reason for the decrease in supply and increase in price of vanadium is the Chinese government forcing some factories and iron ore mines to curtail operations to reduce air pollution. Vanadium is a unique commodity market, as China is both the largest producer and consumer of vanadium. China accounts for about 45% of the world’s vanadium production while Russia and South Africa account for approximately another 30% of global vanadium production.

WSTRF has begun discussions on the economics of building a vanadium and ferro-vanadium processing plant. Ferro-vanadium is a higher value product than vanadium pentoxide, enhancing margins for the Company and shareholders.

Finally, discussions have begun with potential vanadium offtake partners both domestically and internationally.

The aforementioned discussions are early stage and the Company will update the market when further news can be released.

Further, WSTRF Western also announces it has received a bonus payment of $120,000 from signing an oil and gas lease on one of its properties in a hydrocarbon rich region. If oil and/or gas is found, the Company will receive a significant royalty percentage which will be reinvested in the Company’s core vanadium and uranium mining operations. The oil and gas leasing agreement allows the Company to retain full property rights to vanadium, uranium, and other mineral resources.

These strategic positioning decisions are being evaluated relative to cash flow generation potential.  Western is seeking to capitalize on the vanadium and royalty opportunities to generate meaningful cash flow by optimizing and advancing the asset package, in spite of the current low uranium price environment.  These actions would have the added benefit of advancing uranium operations in preparation for when the cycle turns and the market recognizes the imminent global uranium supply deficit.

About Western Uranium Corporation
Western Uranium Corporation is a Colorado based uranium and vanadium conventional mining company focused on low cost near-term production of uranium and vanadium in the western United States and development and application of ablation mining technology.

for more info click link : 

 

Click For Disclaimer

read more

Why is MGTI Continuing to Climb (OTCMKTS:MGTI)

There’s been a lot of news and almost as much movement with MGT Capital Investments, Inc. (OTCMKTS:MGTI) over the past month. First off, the price has almost tripled from where it sat in May ($0.62 on May 15) to $2.35 where it closed on August 18th. The other news is that MGTI just announced yesterday (August 17) that they have obtained and are in the process of deploying 650 state of the art Bitcoin mining rigs which will be located at a new multi-Megawatt facility in the state of Washington. They have said that the new miners will be fully operational within the next two-weeks.

Some background:

Bitcoin’s value rested at about $580 at this time last year (August 2016) just a few months after the latest Mt. Gox issues had hit the market. Anyone who follows Bitcoin knows that the cryptocurrency market is really hot and that Bitcoin currently is in the midst of a steady, high-delta year-long growth spurt which has its value near an all-time high of $4510 on Thursday, August 17 2017.

MGTI

As of Friday, August 18 Bitcoin is still hovering around $4170. This is important for a few reasons: 1) Bitcoin has experienced a strong valuation increase in the past one-month period, which equals its greatest increase since its spike earlier this year between March and June. In July it dived to $1938. 2) The recent split with Bitcoin Cash (called “BCash to avoid confusion) has indirectly caused Bitcoin, with its more established trading infrastructure and global exchange network, to experience increased blockchain activity, trading and value. See, there have been several clonecoins in the past, but BCash also copied the blockchain, meaning that at the time of the fork, every person who owned a Bitcoin also owned a unit of BCash. But there are issues with BCash, not the least of which is its inherent instability and slow blockchain transaction speeds. In addition, 76% of all bitcoin cash that may ever possibly exist, is already in the hands of miners and waiting to be sold. Any time an alternative currency is released, it bolster’s Bitcoin as the de-facto standard crypto, pushing up its price accordingly.

Back to MGTI – Before even announcing their new mining rigs, they surpassed the 1,000 Bitcoins mined milestone – which they have accomplished in less than one year. So we know they’re capable players in this market.

MGTI

They are also reportedly working on a new suite of cyber security technologies in collaboration with industry visionary John McAfee. They aim to develop and launch a series of protection tools for individuals (mobile) and corporations (WANs). MGTI has one such product undergoing beta testing – Sentinel, an enterprise class network intrusion detector – which they will likely release prior to the end of Q3, 2017.

Also, they have formed a JV with Nordic IT with the goal of bringing to market a new mobile phone platform with strong inherent protections for privacy and hacker-thwarting features. Various statements indicate that they intend for development and marketing for this platform to be complete by February of 2018.

The numbers: MGTI is sitting at a humble $2.35 as of close on August 18. This is down from a high of about $3.40 a year ago, but up from a long-term trough which had them languishing as low as $0.68 and volumes hovering in the low 1M range. Average volume is significantly lower at 728,062 which makes current volume of 1,831,411 all the more impressive. Market cap sits at 91.753M and both PE and EPS are negative at -2.07 and -1.14 respectively.

What does this mean? We’re not sure, but we don’t see another dropoff like last year’s. In fact it would be within reason to think that MGTI can ride the Bitcoin wave long enough to bring their other revenue generating strategies online and surpass their all-time high of $3.19 from August of last year. Definitely keep an eye on these guys – and on the Bitcoin and cryptocurrency news.

Click For Disclaimer

read more

FFHD Making Investors Happy

In recent news, FirstAtlantic Financial Holdings (OTCQX: FFHD) or First Atlantic Bank has experienced an uptick in volume. FFHD is a fully reporting holding company for FirstAtlantic Bank, a full service community bank headquartered in Jacksonville, FL. According to their reports, they have $436M in assets, and eight “financial centers” located in eastern Florida. The banking unit has a 5-Star rating from Bauer Financial, Inc. which they claim is the nation’s leading bank rating firm, and a 3-Star rating from Morningstar.

FFHD

There are a few reasons for this volume increase and we’ll get into them in sufficient detail to give the casual investor a likely plan of action. First off, just a few days ago on Ausust 16, 2017 FirstAtlantic Financial Holdings (FFHD) announced a merger with the National Bank of Commerce (NBC) a Delaware corporation headquartered in Alabama. The announcement states that FFHD will continue to operate (and trade) under its own name after the merger is finalized, but the combined institution will reportedly boast approximately $3.1Bn in assets. The parent company of NBC, National Commerce Corporation (NCOM) is listed on NASDAQ.

 

Prior to the merger FFHD stock was trading from $10.40 to $16.85 and according to the terms of the agreement, every share of FFHD stock issued or outstanding prior to the merger will be converted into 0.44 shares of NCC common stock – or – be purchased for $17.25 in cash with a few details pertaining to NCC’s stake in the merger and the effect on outstanding purchase options left to be ironed out in the form of option cancellation and payment of an amount equal to the difference between $17.25 and the option exercise price. For those interested, NCC’s stock has traded between $35.00 and $40.45 through the past three quarters.

NCC has filed a registration statement form S-4 with the SEC to register shares of NCC common stock to be issued to shareholders of FirstAtlantic but FFHD will continue to be operated, managed and traded under its own name for the foreseeable future.

 

The other reasons for the recent uptick include a positive earnings report issued in August and the hire of a new Assistant Vice President.

ffhd

As mentioned previously, FFHD has seen a recent spike in volume. It currently sits at about 95,700, but the 52-week average is still only 7,095. Price as of August 18, a few days after the merger announcement is at $16.76, which is a sharp spike over the previous year, with the price going from around $10 in August of 2016 up to $13.60 a week before the merger.

 

If you’re interested in detailed financial reports and news, these items are available at the company’s website: https://www.firstatlantic.bank/About-Us/Investor-Relations.

 

Based on our analysis, this one is likely to retract just a bit over the next week or so, but a continued steady growth curve topping out at up to $25 within a year or so is definitely not out of the question. Of course, anything could happen including another spike resulting from positive news or greater publicity.

 

Click For Disclaimer

read more
Here’s How And Why BREAKING DATA CORP COM NPV (OTCMKTS:BKDCF) Is Dominating The Online Media Space

Here’s How And Why BREAKING DATA CORP COM NPV (OTCMKTS:BKDCF) Is Dominating The Online Media Space

If a group of people was asked to name the publishing outlet that commands the biggest Facebook page (as defined by the largest number of individual members), chances are companies like BBC or Mashable would be top of the list. Narrow it down to sports media outlets and ESPN would be a top contender. Very few people, if anyone, would return an answer of GiveMeSport. With more than 24 million followers, however, and more than 26 million likes (as of late July 2017) the publisher outperforms all of the above-mentioned household names. For reference, ESPN has the next largest single sports publisher Facebook page with 17 million members.

Why is this important?

Facebook is quickly becoming one of the largest and most prominent news aggregators in the world. The social media platform is an integral part of any content publisher’s arsenal and its dominance in the content serving and sharing space is only expected to grow over the coming decade.

Companies are rushing to figure out how to take advantage of this trend and are having varying degrees of success to this aim. The above mentioned Mashable has created its own technology, called Velocity, that helps it to predict which stories are likely to go viral and when and, in doing so, allows it to capitalize on this early stage information.

Other companies haven’t had as much luck.

The ever changing algorithms that underpin Facebook’s content delivery platform make it difficult to find a sweet spot and even more difficult to maintain it.

So how has GiveMeSport managed to amass such a large following?

The answer is rooted in the company that’s behind the outlet – BREAKING DATA CORP COM NPV (OTCMKTS:BKDCF) (BKD.V) (CVE:BKD). Breaking Data acquired GiveMeSport back in December 2016 and has spent the last six months incorporating its proprietary artificial intelligence (AI) technology into the media outlet’s day to day activity. With this acquisition, not only has Breaking Data given GiveMeSport a considerable technological advantage over its peers, it’s also served to offer public markets an exposure to the outlet’s success (which is what drew the attention of our analysts).

Breaking Data acquired GiveMeSport back in December 2016 and has spent the last six months incorporating its proprietary artificial intelligence (AI) technology into the media outlet’s day to day activity. With this acquisition, not only has Breaking Data given GiveMeSport a considerable technological advantage over its peers, it’s also served to offer public markets an exposure to the outlet’s success (which is what drew the attention of our analysts).

By way of a quick introduction to GiveMeSport and for those not familiar with the platform, it’s a news and entertainment outlet that – as implied by its name – focuses on serving sports related content to its users. The platform is fronted by a website, www.givemesport.com, and traffic is directed to the site through various social channels, including the above mentioned Facebook page.

While this is a website at core, the key thing to recognize here is that Facebook is the real growth driver for the outlet. Its founders are ex-Facebook strategists for various sports stars in the sports and entertainment space and the experience drawn from this side of the operation is what feeds into the company’s success i its Facebook endeavors today.

The way it works is as follows: Breaking Data and GiveMeSport have developed an AI technology that is able to track changes in Facebook’s content algorithm (not directly, but through the impact of the changes on the way the platform’s users interact with GiveMeSport’s content). When it detects changes, it automatically suggests strategic alterations that not only limit the impact of changes on the company’s content’s reach, but also seek to capitalize on it.

This AI approach is what sets GiveMeSport and Breaking Data aside from other publishers in this space. Whereas another publisher may take a 30% hit to its traffic on the back of a Facebook algorithm change and not be able to recover from the hit, GiveMeSport’s AI technology detects the change, mitigates its impact and alters the company’s strategy to try and take advantage of what is ultimately hurting its competitors.

All this is great but it means nothing to an investor in Breaking Data if it doesn’t translate to revenue – so how does Breaking Data generate sales on the traffic it’s attracting through its GiveMeSport platform?

Just as is the case with the vast majority of internet publishers, the answer is through online advertising.

With 32 million monthly visitors (this is a six month old metric but it’s the best we have available, chances are the figure is higher now) GiveMeSport has a very large audience to which it can serve advertisements of all shapes and sizes. Additionally, with a sporting focus, this audience is not only very large, it’s also very diverse. NFL, NHL and NBA fans comprise a large portion of the site’s users and each of these offers a different demographic and user type to the advertisers that want to gain exposure to a potential sales base through the platform.

To date, some of the biggest names in the world have advertised through the GiveMeSport platform, including Mercedes Benz, Bayerische Motoren Werke AG (ETR:BMW), American Express Company (NYSE:AXP) and Electronic Arts Inc. (NASDAQ:EA). These are billion dollar companies achieving quantifiable results through a relationship with GiveMeSport and, by proxy, Breaking Data.

So what’s next?

As per the latest available numbers, Breaking Data generated $1.08 million revenues for the twelve months to January 31, 2017. At that time, however, the GiveMeSport acquisition was less than one month old and the outlet’s advertising revenues were not included in the statement. As such, the next major catalyst for this stock is the reporting of financials (presumably, first quarter, but management hasn’t confirmed when it will start to include GiveMeSport in its audited numbers) that offer insight into just how much of a difference the acquisition makes to Breaking Data’s top and bottom lines.

Beyond that, the outcome of a recently announced marketing strategy that sees the company team up with NFL UK to develop an original content series themed around attempts at Guinness World Records is very much on the catalyst radar.

If this collaboration materializes as expected, it could expand the company’s reach to a television audience and – in turn – could dramatically increase its potential to command premium rates from advertisers looking to gain exposure to its userbase.

Click for disclaimer 

read more
Here’s What To Look For From The Upcoming VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) Phase III Study

Here’s What To Look For From The Upcoming VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) Phase III Study

VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) just announced the details of its long awaited phase III program in hepatitis B. The program, if successful, will underpin registration applications for VBI’s lead hepatitis B asset in the US, Europe and Canada and – as such – its initiation is a major step towards the company dramatically increasing its target population.

Markets are yet to respond to the news, meaning there exists an opportunity right now to get into the stock ahead of VBI revaluing to reflect the operational advance.

With this in mind, here’s a look at the details of the trial, what’s important about how the trial is set up and what to look for going forward as indicative of successful execution and – in turn – a long term bull thesis on the company.

So, as mentioned, it’s a hepatitis B program and it revolves around an asset called Sci-B-Vac. For those new to this company, VBI has developed a platform through which it is able to create next generation vaccines that are designed to build on the immunogenicity and seroprotection offered to patients as part of the current standard of care vaccines. In this instance, the target is hepatitis B and the current standard of care vaccine in this space is Engerix-B.

Engerix-B is effective across a decent portion of the global population but it has its limitations. First, it commands a drawn out dosing regimen, which can lead to non-adherence and – by proxy – a failure of the drug to induce immunization. Second, it’s not particularly effective in certain subgroups of the population; namely, immunosuppressed patients. People with diabetes often fail to achieve seroprotection, even after completing a stringent dosing regimen of Engerix-B. The same is true with elderly patients and patients with chronic kidney disease.

Sci-B-Vac is designed to incorporate three different hepatitis B related antigens, which can help to increase the immunogenicity of the vaccine by increasing the variety of antibodies that are created in response to the vaccine being presented to the immune system. It also doesn’t require the adjuvant that’s generally attached to the standard of care treatment (in the case of Engerix-B, it’s aluminum).

VBI has conducted numerous early and mid stage trials that have demonstrated the safety and efficacy of Sci-B-Vac across a range of population types – regular, immunosuppressed, etc. The drug is also already approved in a number of countries globally and is one of two standard of care hepatitis B vaccines for newborns  (it shares this title with the above discussed Engerix-B) in Israel. This means that, in addition to the data collected formally by the company as part of clinical trials, there also exists a huge data set derived from everyday administrations – all of which prove that this is a safe and effective alternative to the standard of care therapy.

On its own, however, this data isn’t enough to justify approval in the above three noted major markets – the US, Europe and Canada. The regulatory authorities in these regions –  the FDA, the EMA and Health Canada respectively – require an investigator sponsored phase III trial to form the basis of an application for approval and it is this trial for which the company just served up the details.

Before getting into the trial specifics, it’s worth noting that, over the last six months, VBI has put together three pieces of the approval puzzle for this particular asset. Specifically, these pieces are confirmation from the FDA, the EMA and Health Canada that a single, global phase III program would be enough to underpin an application in each region. In other words, confirmation that the company won’t have to conduct three separate programs, one for each region. This confirmation from Europe and Canada came back in February. Markets had to wait a little longer for US confirmation but it eventually came in June.

This latest release, then, confirming trial design, is a fourth piece of the puzzle and the final one necessary before initiation.

So, let’s look at the trial.

As mentioned, it’s a single global program that’s set up to underpin registration applications in the US, Europe, and Canada and, according to the study design, it’s going to consist of two phase III studies. The first will be a safety and immunogenicity study called PROTECT and the second will be what’s called a lot-to-lot consistency study called CONSTANT. All told, both studies will enroll approximately 4,800 subjects and will be conducted at approximately 40 sites across the U.S., Europe, and Canada.

It’s worth noting here that a count of 4,800 patients is relatively low for a pivotal trial in a common indication like hepatitis B. The reason that the company is able to keep this number so low is that, as described above, there already exists a large set of data supportive of safety and efficacy. According to the company’s latest release, this set includes data from more than 2,000 patients.

Anyway, let’s look at the two phase III trials.

The PROTECT study will be a double-blind, two-arm, randomized, controlled study, enrolling approximately 1,600 adult subjects all of which are age 18 years and older. Subsequent opt enrollment, the patients will be randomized in a 1:1 ratio to receive either a three-dose course of Sci-B-Vac (at a 10μg dose) or a three-dose course of the control vaccine, which is the above discussed Engerix-B (at a 20μg dose).

There are two primary endpoints associated with the study.

The first is the demonstration of non-inferiority of the seroprotection rate induced by the active drug versus the control drug, four weeks after the third vaccination. This one relates specifically to patients aged 18 and older.

The second is the same, but superiority (as opposed to non-inferiority) in patients aged 45 and older. This one is an attempt to prove that the drug can be more effective in the immunocompromised population, as discussed above.

The CONSTANT study is a double-blind, four-arm, randomized, controlled study that will enroll approximately 3,200 adult subjects, age 18-45 years. In this one, the patients will be randomized in a 1:1:1:1 ratio to receive one of four three-dose courses – Lot A of Sci-B-Vac 10μg, Lot B of Sci-B-Vac 10μg, Lot C of Sci-B-Vac 10μg, or the control vaccine Engerix-B 20μg.

For those not familiar with these lot-type studies, the point is to show that the effect that the drug has on the patients is the same across a variety of different lots (just think of these as batches) of the drug in question. In this instance, VBI is trying to show to the regulatory agencies that Sci-B-Vac is consistently manufactured and – by proxy – has a consistent impact (in terms of seroprotection induced) across a range of different batches. The consistency in this instance is measured using what’s called geometric mean concentration (GMC) of antibodies.

The best way to think of this second study is as it being a study geared towards demonstrating a consistency of quality of the product, as opposed to specifically addressing efficacy. Of course, safety and efficacy will be measured (in fact, they comprise the secondary endpoint of this particular part of the program), as these metrics will also be used to measure quality across batches.

So, what are we looking for from the trials as indicative of success?

From the first study, we want to see two things.

First, that the drug is as effective in inducing seroprotection in adults aged 18 plus as is Engerix-B. That’s sort of the core primary endpoint. The second primary endpoint, however, the one looking at patients aged 45 plus in this author’s opinion, is more interesting. Not necessarily more important, as the primary needs to be hit, but more interesting.

Why?

Because there’s a very large market available to VBI if it can show that its asset is superior to Engerix-B in immunosuppressed patients. This second primary endpoint is geared towards proving just that.

From the second phase III, we just want to see safety and consistency between lots. It would be nice to see superiority in efficacy as compared to the individual lots and Engerix-B but it’s not essential.

As far as timelines are concerned, VBI hasn’t served up any specific dates for enrollment initiation but the company expects to kick off both studies during the second half of this year. With a 15-month time to completion, this means we should see topline hit press during the first half of 2018.

Disclosure: The author has no shares in any of the stocks mentioned in this article. 

read more